TITLE

Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females

AUTHOR(S)
Derakhshan, M. H.; Liptrot, S.; Paul, J.; Brown, I. L.; Morrison, D.; McColl, K. E. L.
PUB. DATE
January 2009
SOURCE
Gut;Jan2009, Vol. 58 Issue 1, p16
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Upper gastrointestinal adenocarcinomas show an unexplained male predominance that is more apparent in oesophagus than stomach and in intestinal than diffuse histological subtype. We have conducted a population-based study to determine whether the gender phenomenon is primarily related to the anatomical site or the histological subtype. Method and materials: Of 3270 gastric and oesophageal cancers recorded in the West of Scotland Cancer Registry, 1998-2002, 812 were randomly selected for detailed analysis. The Lauren histological subtype of adenocarcinoma was determined by reviewing 1204 original reports and 3241 biopsies. Results: Analysis included 405 non-cardia cancers, 173 cardia cancers and 209 oesophageal adenocarcinomas. Crude incidence rate of intestinal subtype was higher in males (23.86/1 00 000 person-years) versus females (9.00/1 00 000 person-years), giving a male/female (M/F) ratio of 2.65 whereas diffuse subtype was similar for both genders (5.58 vs 5.20/1 00 000 person-years) yielding M/ F of 1.07. The M/F ratios for oesophageal, cardia and non- cardia gastric cancer were 3.5, 2.0 and 1.6, respectively. Multiple logistic regression indicated that the odds of male gender was related to the histological subtype rather than anatomical location (odds ratio 2.6, 95% confidence interval 1.78 to 3.9). Curve fitting of the age-specific incidence of intestinal subtype indicated that similar functions describe the rise in incidence with age in males and in females. However, the age-specific incidence of female intestinal subtype was delayed by 17.3 years. The M/F ratio of intestinal subtype was 3.41 at age <50 years, peaked at 7.86 at age 50-59 years and then showed a progressive decrease after 50-60 years of age. Conclusion: Male predominance of upper gastrointestinal adenocarcinoma is related to the intestinal histological subtype rather than tumour location and is due to marked delayed development of this subtype in females prior to 50-60 years of age.
ACCESSION #
35965700

 

Related Articles

  • Esophageal Adenocarcinoma in “Mice and Men”: Back to Basics! Attwood, Stephen E.; Harrison, Lea-Anne; Preston, Sean L.; Jankowski, Janusz A. // American Journal of Gastroenterology;Sep2008, Vol. 103 Issue 9, p2367 

    Adenocarcinoma related to Barrett's esophagus (BE) is increasing in the West faster than any other cancer. There are many potential chemopreventive agents as well as predictive biomarkers of cancer progression, but what is required is a robust high-throughput model in which to test hypotheses...

  • Low Proportion of Barrett's Esophagus in Asian Americans. Lam, Khoa D.; Phan, Jeanine T.; Garcia, Ruel T.; Trinh, Huy; Nguyen, Huy; Nguyen, Khanh; Triadafilopoulos, George; Vutien, Philip; Nguyen, Long; Nguyen, Mindie H. // American Journal of Gastroenterology;Jul2008, Vol. 103 Issue 7, p1625 

    OBJECTIVES: To determine the proportion of Barrett's esophagus (BE) in Asians versus non-Asians and the predictors of BE in patients with upper gastrointestinal (GI) symptoms. METHODS: We performed a cross-sectional study to determine the proportion of BE from all consecutive patients who...

  • Barrett's Esophagus and Cancer Risk: How Research Advances Can Impact Clinical Practice. di Pietro, Massimiliano; Alzoubaidi, Durayd; Fitzgerald, Rebecca C. // Gut & Liver;Jul2014, Vol. 8 Issue 4, p356 

    Barrett's esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), whose incidence has increased sharply in the last 4 decades. The annual conversion rate of BE to cancer is significant, but small. The identification of patients at a higher risk of cancer therefore poses a...

  • Diagnosis and grading of dysplasia in Barrett’s oesophagus. R D Odze // Journal of Clinical Pathology;Oct2006, Vol. 59 Issue 10, p1029 

    This review focuses on the pathological features of dysplasia in Barrett’s oesophagus. Two categorisation schemes are used for grading dysplasia in the gastrointestinal tract, including Barrett’s oesophagus. The inflammatory bowel disease dysplasia morphology study group system is...

  • Elevated Serum Gastrin Is Associated With a History of Advanced Neoplasia in Barrett's Esophagus. Wang, Judy S; Varro, Andrea; Lightdale, Charles J; Lertkowit, Nantaporn; Slack, Kristen N; Fingerhood, Michael L; Tsai, Wei Yann; Wang, Timothy C; Abrams, Julian A // American Journal of Gastroenterology;May2010, Vol. 105 Issue 5, p1039 

    OBJECTIVES:Proton pump inhibitors (PPIs) are frequently prescribed to patients with Barrett's esophagus (BE), but in a subset, they can induce significant hypergastrinemia. Elevated levels of gastrin have been associated with tumorigenic effects in a number of gastrointestinal cancers. We...

  • Gastric Cancer in a Young Adult. Dobkin, Jeffrey A.; Schubert, Timothy T. // American Journal of Gastroenterology;Jul1986, Vol. 81 Issue 7, p607 

    We report a case of gastric adenocarcinoma in a 23-yr- old white man. Since only 1% of gastric cancers occur in patients under 35 yr or age, the diagnosis is often overlooked. The presence of persistent pain, weight loss, early satiety, anemia, and vomiting are clues to the underlying disorder....

  • Diagnosis and treatment of Barrett's oesophagus. Lim, Yean Cheant; Fitzgerald, Rebecca C. // British Medical Bulletin;Sep2013, Vol. 107 Issue 1, p117 

    Introduction Barrett's oesophagus (BO) is a common premalignant condition, which carries a risk of progression to oesophageal adenocarcinoma. Recent advances include quantifying the risk of neoplasia progression, novel diagnostic tools and development of new endoscopic techniques to treat early...

  • Barrett's Adenocarcinoma of the Esophagus. Behrens, Angelika; Pech, Oliver; Graupe, Florian; May, Andrea; Lorenz, Dietmar; Ell, Christian // Deutsches Aerzteblatt International;5/6/2011, Vol. 108 Issue 18, following p319 

    A bibliography on the subject of new methods of diagnosis and treatment is presented which includes articles "Acid has antiproliferative effects in nonoplastic Barrett's epithelial cells,' by Feagins L. A. and colleagues, "Selective inhibition of cyclooxygenase 2 suppresses growth and induces...

  • Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus. Wang, Kenneth K.; Sampliner, Richard E. // American Journal of Gastroenterology;Mar2008, Vol. 103 Issue 3, p788 

    The article provides information on the revision made on the 2008 Guidelines for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus. The guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus were originally published by the American College of Gastroenterology...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics